Related Experiment Video
Updated: Aug 6, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
314
Prognostic risk factors and nomogram construction for sebaceous carcinoma: A population-based analysis
Wen Xu1, Yijun Le2, Jianzhong Zhang1
1Department of Dermatology, Peking University People's Hospital, Beijing, China.
Frontiers in Oncology
|March 16, 2023
Summary
This study developed a new nomogram to predict survival for sebaceous gland carcinoma (SGC) patients. The tool accurately forecasts 3-, 5-, and 10-year survival rates, aiding in early identification of high-risk individuals.
Area of Science:
- Oncology
- Dermatology
- Biostatistics
Background:
- Sebaceous gland carcinoma (SGC) is a rare malignancy lacking effective prognostic tools.
- Accurate prediction of patient outcomes is crucial for effective management of SGC.
Purpose of the Study:
- To analyze clinical and pathological prognostic risk factors for SGC.
- To develop a nomogram for predicting overall survival (OS) rates in SGC patients.
Main Methods:
- Utilized data from 2844 SGC patients (2004-2015) from the SEER database.
- Employed univariate and multivariate COX regression to identify risk factors.
- Constructed and validated a nomogram using training and validation cohorts.
Main Results:
- The nomogram demonstrated good predictive power with a C-index of 0.725 in the training cohort and 0.710 in the validation cohort.
- AUC curves and calibration plots confirmed the nomogram's accuracy for 3-, 5-, and 10-year OS.
- Decision curve analysis indicated clinical utility for the developed nomogram.
Conclusions:
- A novel nomogram for SGC prognostic factors was successfully created.
- The nomogram provides accurate and comprehensive prediction of OS, aiding clinical decision-making.
- Early identification of high-risk SGC patients can facilitate personalized treatment and improve survival rates.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
407
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
407
Skin Cancer
4.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.3K

